NYSE American - Nasdaq Real Time Price USD
Armata Pharmaceuticals, Inc. (ARMP)
2.2500
-0.1200
(-5.06%)
At close: 4:00:00 PM EDT
2.3082
+0.06
+(2.59%)
After hours: 4:48:38 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
40,399
42,436
40,890
36,946
23,822
Operating Income
-40,399
-42,436
-40,890
-36,946
-23,822
Net Non Operating Interest Income Expense
-11,820
-10,045
-2,447
29
-59
Other Income Expense
51,793
33,565
-25,708
--
726
Pretax Income
-426
-18,916
-69,045
-36,917
-23,155
Net Income Common Stockholders
-426
-18,916
-69,045
-36,917
-23,155
Diluted NI Available to Com Stockholders
-5,629
-18,916
-69,045
-36,917
-23,155
Basic EPS
-0.01
-0.52
-1.91
-1.08
-0.96
Diluted EPS
-0.40
-0.89
-1.91
-1.08
-0.96
Basic Average Shares
36,175.8040
36,160.8480
36,075.5550
34,294.1240
24,104.1460
Diluted Average Shares
64,898.3920
59,059.9710
36,075.5550
34,294.1240
24,104.1460
Total Operating Income as Reported
-40,399
-42,436
-40,890
-36,946
-23,822
Total Expenses
40,399
42,436
40,890
36,946
23,822
Net Income from Continuing & Discontinued Operation
-426
-18,916
-69,045
-36,917
-23,155
Normalized Income
-2,592
-21,082
-65,182
-36,917
-23,881
Interest Income
704
697
179
29
5
Interest Expense
12,524
10,742
2,626
0
64
Net Interest Income
-11,820
-10,045
-2,447
29
-59
EBIT
12,098
-8,174
-66,419
-36,917
-23,091
EBITDA
13,483
-6,849
-65,447
-36,025
-21,922
Reconciled Depreciation
1,385
1,325
972
892
1,169
Net Income from Continuing Operation Net Minority Interest
-426
-18,916
-69,045
-36,917
-23,155
Total Unusual Items Excluding Goodwill
2,166
2,166
-3,863
0
726
Total Unusual Items
2,166
2,166
-3,863
0
726
Normalized EBITDA
11,317
-9,015
-61,584
-36,025
-22,648
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/20/1994
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TNGX Tango Therapeutics, Inc.
2.0700
-9.61%
ABP Abpro Corporation
0.2549
-6.29%
BCLI Brainstorm Cell Therapeutics Inc.
1.2400
-8.82%
EYEN Eyenovia, Inc.
1.6700
+47.79%
KLTO Klotho Neurosciences, Inc.
0.2175
-5.84%
XLO Xilio Therapeutics, Inc.
0.8982
+2.07%
ONCO Onconetix, Inc.
0.0880
+8.37%
QNRX Quoin Pharmaceuticals, Ltd.
8.47
+6.01%
CNSP CNS Pharmaceuticals, Inc.
1.2900
0.00%
CABA Cabaletta Bio, Inc.
1.8800
-2.08%